Asthma
COPD
Pulmonary
Search
Article
Blog
Company
Podcast
Product
Video
Whitepaper
Enter search phrase
Search
Pulmonary
MRI reduces cognitive failure, adverse events in SCLC
Analysis supports MRI surveillance alone, rather than preventive brain radiation, as the standard of care approach for patients with small-cell lung cancer.
September 24, 2026
Asthma
Is there a ‘window of opportunity’ for biologic treatment in severe asthma?
AI, biologic biomarkers and digital health tools that evaluate treatment timing could help prevent irreversible airway damage.
September 24, 2026
Asthma
Semaglutide significantly lowers asthma, COPD attacks
Scientific community should consider metabolic health as part of future respiratory therapies.
September 24, 2026
COPD
Research aims to develop better tools for dyspnea detection
University of California researcher to launch five-year project to better understand dyspnea in COPD patients.
September 23, 2026
COPD
Novel inhaled treatment for COPD shows promise in clinical trial
Metered spray treatment demonstrated clinically meaningful improvements in quality of life and COPD symptoms.
September 23, 2026
Pulmonary
Common cold: There may be a vaccine for that
Early clinical trial results demonstrate safety and efficacy in preventing rhinovirus-related COPD and asthma exacerbations.
September 18, 2026
Pulmonary
Inpatient PAH therapy transition deemed safe
Research supports concurrent switch from infusion treatment to oral medication over a closely monitored, continuous timeframe averaging 36 hours.
September 17, 2026
COPD
FDA approves study of inhaled stem cell therapy for COPD
The investigational drug is scheduled for a phase 1b trial in late 2026.
September 17, 2026
COPD
Childhood pollution exposure linked to COPD
Children with a higher genetic risk showed reduced lung development but only when exposed to pollution.
September 17, 2026
Asthma
Experimental bacterial extract fails to prevent pediatric wheezing or asthma
Common childhood illnesses, such as fevers, coughs and colds, occurred at similar rates in drug and placebo groups.
September 17, 2026
Asthma
Tiotropium safe for preschool asthma but not more effective
German researchers evaluated benefits of the inhaled muscle relaxant in preschool-aged children
with severe asthma.
September 17, 2026
Pulmonary
Foretelling the future of lung cancer recurrence
Researchers have discovered multiple noninvasive ways to predict risk and improve outcomes.
September 11, 2026
Asthma
Fatal asthma may be driven by immune dysfunction beyond the lungs
Previously hidden links between the gut, lymph nodes and lungs reveal why some asthma attacks become deadly.
September 10, 2026
Asthma
Asthma Control Questionnaire better captures patients’ well-being
Commonly used asthma assessment tool may provide deeper insights into how patients feel and function in daily life.
September 10, 2026
COPD
Getting the last laugh on COPD
Clinical trial suggests laugher therapy may help patients with COPD reduce breathing difficulties.
September 10, 2026
COPD
Investigational therapy shows promise in treating COPD
Clinical trials show significant reduction in flareups with investigational biologic therapy tozorakimab.
September 10, 2026
Pulmonary
Seniors with lung disease benefit from 4x stronger flu vaccine
International studies confirmed the high-dose flu vaccine reduced hospitalizations in the high-risk population by almost 9%.
September 9, 2026
Asthma
AstraZeneca, Amgen report success for Tezspire in late-stage esophageal disease trial
Investigators noted improvements in alleviating issues swallowing food and other daily life challenges associated with EoE.
September 3, 2026
Next Page
